Platelet reactivity and antiplatelet management in diabetic patients with coronary artery disease (original) (raw)

Platelet Mediated Inflammation in Coronary Artery Disease with Type 2 Diabetes Patients

Journal of Inflammation Research, 2021

Antiplatelet and antithrombotic therapy in diabetic patients recent updates

International journal of applied research, 2021

Comparison of Platelet Reactivity and Periprocedural Outcomes in Patients With Versus Without Diabetes Mellitus and Treated With Clopidogrel and Percutaneous Coronary Intervention

Germano Sciascio

The American Journal of Cardiology, 2010

View PDFchevron_right

Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin

G. Dell’Elba

Journal of Thrombosis and Haemostasis, 2007

View PDFchevron_right

Platelet Aggregation is not Enhanced in Patients with Prediabetes

Selim Kiliç

Upsala Journal of Medical Sciences, 2007

View PDFchevron_right

Platelet Response to Aspirin 50 and 100 mg in Patients With Coronary Heart Disease Over a Five-Year Period

Robert Berent

The American Journal of Cardiology, 2011

View PDFchevron_right

Platelet activation and its patient-specific consequences

Waldemar Wysokinski

2008

View PDFchevron_right

Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)

Shmuel Chen

The American Journal of Cardiology, 2019

View PDFchevron_right

Influence of glycaemic control on platelet count in type II diabetics in absence of vascular complications

Farah Bahmed

MedPulse International Journal of Physiology

View PDFchevron_right

Refractoriness of diabetic platelets to inhibitory prostaglandins

Michel Lagarde

Prostaglandins and Medicine, 1981

View PDFchevron_right

Alterations of platelet biochemical and functional properties in newly diagnosed type 1 diabetes: a role in cardiovascular risk?

Orazio Gabrielli

Diabetes/Metabolism Research and Reviews, 2011

View PDFchevron_right

Increased Platelet Reactivity and Circulating Monocyte-Platelet Aggregates in Patients With Stable Coronary Artery Disease

Stephen Benoit

Journal of the American College of Cardiology, 1998

View PDFchevron_right

Altered lysis resistance of platelet-rich clots in patients with insulin-dependent diabetes mellitus

Emöke Pósán

1995

View PDFchevron_right

Quiescent Platelets Stimulate Angiogenesis and Diabetic Wound Repair

Dennis Orgill

Journal of Surgical Research, 2010

View PDFchevron_right

Antiplatelet Therapy, Diabetic Neuropathy and Peripheral Vascular Disease: A Unitary Approach

Raymond L Rosales

Journal of diabetes & metabolism, 2012

View PDFchevron_right

Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events

B. Van Hout

American Journal of Cardiovascular Drugs, 2009

View PDFchevron_right

Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests

Yulia Einav

Thrombosis Research, 2008

View PDFchevron_right

Concurrent Morning Increase in Platelet Aggregability and the Risk of Myocardial Infarction and Sudden Cardiac Death

Charles Czeisler

New England Journal of Medicine, 1987

View PDFchevron_right

Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus

G. Kudolo

Prostaglandins & Other Lipid Mediators, 1999

View PDFchevron_right

The association between platelet/lymphocyte ratio and coronary artery disease severity

Hasan Kaya

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2014

View PDFchevron_right

Clinical Evaluation of Platelet Concentrates Either in Plasma or in Additive Solution

Cristina Arbona

The Open Hematology Journal, 2008

View PDFchevron_right

Evaluation of platelet-rich plasma from diabetic donors shows increased platelet vascular endothelial growth factor release

Komang Wahyuningsih

Stem Cell Investigation, 2019

View PDFchevron_right

long-term treated patients Inhibition of platelet aggregation by aspirin progressively decreases in

pasquale pignatelli

2010

View PDFchevron_right

Aspirin resistance measured by cationic propyl gallate platelet aggregometry and recurrent cardiovascular events during 4 years of follow-up

Borek Lacnak

European Journal of Internal Medicine, 2006

View PDFchevron_right

Effect of platelet-activating factor on lipoprotein lipase and blood lipids

Masatoshi Mune

Lipids, 1991

View PDFchevron_right

Weight loss surgery decreases platelet activation in morbidly obese patients

Elena Galkina

The FASEB Journal, 2012

View PDFchevron_right

Platelet production: A computer based biological interpretation

Yehia Kishk

Thrombosis Research, 1983

View PDFchevron_right

Better detection of platelet aggregation in patients with metabolic syndrome using epinephrine and ADP

Eduardo Perez Campos

Diabetology & Metabolic Syndrome, 2014

View PDFchevron_right

Evaluation of the relationship between serum apelin levels and vitamin D and mean platelet volume in diabetic patients

Cumali Karatoprak

Annales d'Endocrinologie, 2014

View PDFchevron_right

Antioxidants change platelet responses to various stimulating events

Martin Malý

Free Radical Biology and Medicine, 2009

View PDFchevron_right

The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary

Philip Teal

Canadian Journal of Cardiology, 2011

View PDFchevron_right

Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study

Dean Kereiakes

Circulation, 2016

View PDFchevron_right

Comorbidity and low use of new antiplatelets in acute coronary syndrome

Antonia Sambola

Aging Clinical and Experimental Research, 2019

View PDFchevron_right

Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets

Joerg Geiger

Journal of Thrombosis and Haemostasis, 2008

View PDFchevron_right

Glycoxidized HDL, HDL enriched with oxidized phospholipids and HDL from diabetic patients inhibit platelet function

Michel Lagarde

The Journal of Clinical Endocrinology & Metabolism, 2015

View PDFchevron_right

Platelet reactivity and antiplatelet management in diabetic patients with coronary artery disease (original) (raw)

Related papers